LightEdge Asset Management (LEAM) is a global investment firm focused on high-conviction, research-driven opportunities across global markets. LightEdge Asset Management (LEAM) is looking for an Equity Research Analyst with 3–4 years of experience covering the Biotechnology / Biopharma sector , primarily across US and European equities .
Responsibilities
- Cover biotech and biopharma companies across the US and Europe.
- Evaluate clinical pipelines, trial data, catalysts, and competitive positioning.
- Track FDA, EMA, and other key regulatory developments.
- Analyze early- to late-stage biotech companies and identify investment opportunities.
- Translate scientific and clinical developments into clear investment views.
- Present actionable long and short ideas to the investment team.
Requirements
- 3–4 years of direct biotech or biopharma equity research experience.
- Strong understanding of clinical trials, drug development, and regulatory frameworks.
- Deep knowledge of US and European biotechnology markets.
- Strong ability to connect scientific developments with stock-specific investment implications.
- Proven track record of generating actionable investment ideas.
Show more Show less